Comera Life Sciences Inc...
(CMRA)
undefined
undefined%
At close: undefined
0.09
44900.00%
After-hours Nov 16, 2023, 07:58 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY22 | FY21 | FY20 |
| Net Income | -18.00M | -5.45M | -2.13M |
| Depreciation & Amortization | 93.95K | 86.14K | 89.75K |
| Stock-Based Compensation | 375.79K | 1.11M | 101.04K |
| Other Working Capital | 1.72M | -28.95K | -26.05K |
| Other Non-Cash Items | 5.21M | 79.42K | 171.10K |
| Deferred Income Tax | n/a | -160.59K | 1.39K |
| Change in Working Capital | 2.55M | 574.20K | -41.90K |
| Operating Cash Flow | -9.77M | -3.76M | -1.80M |
| Capital Expenditures | -28.61K | -142.01K | -12.37K |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -107.09M |
| Sales Maturities Of Investments | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a |
| Investing Cash Flow | -28.61K | -142.01K | -12.37K |
| Debt Repayment | n/a | 750.00K | 160.59K |
| Common Stock Repurchased | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | 4.41M | 9.53M | n/a |
| Financial Cash Flow | 5.24M | 10.28M | 1.55M |
| Net Cash Flow | -4.56M | 6.38M | -264.14K |
| Free Cash Flow | -9.80M | -3.90M | -1.82M |